International Alliance of Urolithiasis (IAU) guideline on staghorn calculi management.

Guideline Kidney stones Staghorn calculi Treatment Urolithiasis

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
25 Mar 2024
Historique:
received: 02 08 2023
accepted: 16 01 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: epublish

Résumé

The stone burden based management strategy reported in the guidelines published by different associations is well known for a long time. Staghorn calculi, representing the largest burden and most complex stones, is one of the most challenging cases to practicing urologists in clinical practice. The International Alliance of Urolithiasis (IAU) has released a series of guidelines on the management of urolithiasis. To develop a series of recommendations for the contemporary management management of staghorn calculi and to provide a clinical framework for urologists treating patients with these complex stones. A comprehensive literature search for articles published in English between 01/01/1976 and 31/12/2022 in the PubMed, OVID, Embase and Medline database is performed. A series of recommendations are developed and individually graded following the review of literature and panel discussion. The definition, pathogenesis, pathophysiology, preoperative evaluation, intraoperative treatment strategies and procedural advice, early postoperative management, follow up and prevention of stone recurrence are summarized in the present document. A series of recommendations regarding the management of staghorn calculi, along with related commentary and supporting documentation offered in the present guideline is intended to provide a clinical framework for the practicing urologists in the management of staghorn calculi.

Sections du résumé

BACKGROUND BACKGROUND
The stone burden based management strategy reported in the guidelines published by different associations is well known for a long time. Staghorn calculi, representing the largest burden and most complex stones, is one of the most challenging cases to practicing urologists in clinical practice. The International Alliance of Urolithiasis (IAU) has released a series of guidelines on the management of urolithiasis.
PURPOSE OBJECTIVE
To develop a series of recommendations for the contemporary management management of staghorn calculi and to provide a clinical framework for urologists treating patients with these complex stones.
METHODS METHODS
A comprehensive literature search for articles published in English between 01/01/1976 and 31/12/2022 in the PubMed, OVID, Embase and Medline database is performed. A series of recommendations are developed and individually graded following the review of literature and panel discussion.
RESULTS RESULTS
The definition, pathogenesis, pathophysiology, preoperative evaluation, intraoperative treatment strategies and procedural advice, early postoperative management, follow up and prevention of stone recurrence are summarized in the present document.
CONCLUSION CONCLUSIONS
A series of recommendations regarding the management of staghorn calculi, along with related commentary and supporting documentation offered in the present guideline is intended to provide a clinical framework for the practicing urologists in the management of staghorn calculi.

Identifiants

DOI: 10.1007/s00345-024-04816-6 PMID: 38526675
pubmed: 38526675
doi: 10.1007/s00345-024-04816-6
pii: 10.1007/s00345-024-04816-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Zeng G, Mai Z, Xia S et al (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120:109–116
pubmed: 28236332 doi: 10.1111/bju.13828
Assimos D, Krambeck A, Miller NL et al (2016) Surgical management of stones: American urological association/endourological society guideline. J Urol 196:1153–1169
pubmed: 27238616 doi: 10.1016/j.juro.2016.05.090
EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam (2022) ISBN 978-94-92671-16-5. https://uroweb.org/guidelines/urolithiasis
Preminger GM, Assimos DG, Lingeman JE et al (2005) AUA Nephrolithiasis Guideline Panel). Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173:1991–2000
pubmed: 15879803 doi: 10.1097/01.ju.0000161171.67806.2a
Zeng G, Zhong W, Mazzon G et al (2022) International Alliance of Urolithiasis (IAU) guideline on percutaneous nephrolithotomy. Minerva Urol Nephrol 74:653–668
pubmed: 35099162
Zeng G, Traxer O, Zhong W et al (2023) International Alliance of Urolithiasis guideline on retrograde intrarenal surgery. BJU Int 131:153–164
pubmed: 35733358 doi: 10.1111/bju.15836
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926
pubmed: 18436948 pmcid: 2335261 doi: 10.1136/bmj.39489.470347.AD
OCEBM Levels of Evidence Working Group OCEBM Levels of Evidence. Available online:  http://www.cebm.net
Healy KA, Ogan K (2007) Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am 34:363–374
pubmed: 17678986 doi: 10.1016/j.ucl.2007.05.006
Diri A, Diri B (2018) Management of staghorn renal stones. Ren Fail 40:357–362
pubmed: 29658394 pmcid: 6014528 doi: 10.1080/0886022X.2018.1459306
Segura JW (1997) Staghorn calculi. Urol Clin North Am 24(1):71–80
pubmed: 9048853 doi: 10.1016/S0094-0143(05)70355-4
Viprakasit DP, Sawyer MD, Herrell SD, Miller NL (2011) Changing composition of staghorn calculi. J Urol 186:2285–2290
pubmed: 22014820 doi: 10.1016/j.juro.2011.07.089
Lerner SP, Gleeson MJ, Griffith DP (1989) Infection stones. J Urol 141:753–758
pubmed: 2645435 doi: 10.1016/S0022-5347(17)41002-0
Torricelli FCM, Monga M (2020) Staghorn renal stones: what the urologist needs to know. Int Braz J Urol 46:927–933
pubmed: 32213203 pmcid: 7527092 doi: 10.1590/s1677-5538.ibju.2020.99.07
Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241
pubmed: 20071471 doi: 10.1001/jama.2009.2014
Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392
pubmed: 14717908 doi: 10.1111/j.1523-1755.2004.00386.x
Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106–113
pubmed: 14742848 doi: 10.1038/oby.2004.14
Cupisti A, Meola M, D’Alessandro C et al (2007) Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 61:86–90
pubmed: 17184967 doi: 10.1016/j.biopha.2006.09.012
Gettman MT, Segura JW (1999) Struvite stones: diagnosis and current treatment concepts. J Endourol 13:653–658
pubmed: 10608517 doi: 10.1089/end.1999.13.653
Brain E, Geraghty RM, Cook P, Roderick P, Somani B (2021) Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol 39:3095–3101
pubmed: 33403436 pmcid: 8405492 doi: 10.1007/s00345-020-03564-7
Cohen TD, Preminger GM (1996) Struvite calculi. Semin Nephrol 16(5):425–434
pubmed: 8890398
Parkhomenko E, De Fazio A, Tran T, Thai J, Blum K, Gupta M (2017) A multi-institutional study of struvite stones: patterns of infection and colonization. J Endourol 31:533–537
pubmed: 28355093 doi: 10.1089/end.2016.0885
Koga S, Arakaki Y, Matsuoka M, Ohyama C (1991) Staghorn calculi–long-term results of management. Br J Urol 68:122–124
pubmed: 1884136 doi: 10.1111/j.1464-410X.1991.tb15278.x
Blandy JP, Singh M (1976) The case for a more aggressive approach to staghorn stones. J Urol 115:505–506
pubmed: 1271539 doi: 10.1016/S0022-5347(17)59258-7
Chen D, Jiang C, Liang X et al (2019) Early and rapid prediction of postoperative infections following percutaneous nephrolithotomy in patients with complex kidney stones. BJU Int 123:1041–1047
pubmed: 30007112 doi: 10.1111/bju.14484
He C, Chen H, Li Y, Zeng F, Cui Y, Chen Z (2021) Antibiotic administration for negative midstream urine culture patients before percutaneous nephrolithotomy. Urolithiasis 49:505–512
pubmed: 33710365 doi: 10.1007/s00240-021-01260-8
Amier Y, Zhang Y, Zhang J et al (2022) Analysis of preoperative risk factors for postoperative urosepsis after mini-percutaneous nephrolithotomy in patients with large kidney stones. J Endourol 36:292–297
pubmed: 34569289 doi: 10.1089/end.2021.0406
El Tayeb MM, Knoedler JJ, Krambeck AE, Paonessa JE, Mellon MJ, Lingeman JE (2015) Vascular complications after percutaneous nephrolithotomy: 10 years of experience. Urology 85:777–781
pubmed: 25704996 doi: 10.1016/j.urology.2014.12.044
Li Z, Wu A, Liu J et al (2020) Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy: a meta-analysis. Transl Androl Urol 9:210–217
pubmed: 32420126 pmcid: 7214970 doi: 10.21037/tau.2020.01.10
Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30:10–16
pubmed: 20162247 doi: 10.1055/s-0037-1617143
Ghani KR, Patel U, Anson K (2009) Computed tomography for percutaneous renal access. J Endourol 23:1633–1639
pubmed: 19814578 doi: 10.1089/end.2009.1529
Klein I, Gutiérrez-Aceves J (2020) Preoperative imaging in staghorn calculi, planning and decision making in management of staghorn calculi. Asian J Urol 7:87–93
pubmed: 32257800 doi: 10.1016/j.ajur.2019.07.002
Thiruchelvam N, Mostafid H, Ubhayakar G (2005) Planning percutaneous nephrolithotomy using multidetector computed tomography urography, multiplanar reconstruction and three-dimensional reformatting. BJU Int 95:1280–1284
pubmed: 15892817 doi: 10.1111/j.1464-410X.2005.05519.x
Tan H, Xie Y, Zhang X, Wang W, Yuan H, Lin C (2021) Assessment of three-dimensional reconstruction in percutaneous nephrolithotomy for complex renal calculi treatment. Front Surg 8:701207
pubmed: 34746220 pmcid: 8564007 doi: 10.3389/fsurg.2021.701207
Wu WJ, Okeke Z (2017) Current clinical scoring systems of percutaneous nephrolithotomy outcomes. Nat Rev Urol 14:459–469
pubmed: 28534536 doi: 10.1038/nrurol.2017.71
Yarimoglu S, Bozkurt IH, Aydogdu O et al (2017) External validation and comparison of the scoring systems (S.T.O.N.E, GUY, CROES, S-ReSC) for predicting percutaneous nephrolithotomy outcomes for staghorn stones: a single center experience with 160 cases. Kaohsiung J Med Sci 33:516–522
pubmed: 28962823 doi: 10.1016/j.kjms.2017.06.017
Huynh LM, Huang E, Patel RM, Okhunov Z (2017) Predictability and practicality of image-based scoring systems for patient assessment and outcome stratification during percutaneous nephrolithotomy: a contemporary update. Curr Urol Rep 18:95
pubmed: 29046986 doi: 10.1007/s11934-017-0740-5
Ganpule AP, Desai M (2008) Management of the staghorn calculus: multiple-tract versus single-tract percutaneous nephrolithotomy. Curr Opin Urol 18:220–223
pubmed: 18303548 doi: 10.1097/MOU.0b013e3282f3e6e4
Mehra K, Satpathy P, Joshi A, Manikandan R (2022) Percutaneous nephrolithotomy in patients with chronic kidney disease: a systematic review. Urol Int 106:461–468
pubmed: 35045417 doi: 10.1159/000520266
Talwar HS, Mittal A, Panwar VK et al (2022) Efficacy and safety of percutaneous nephrolithotomy in patients with chronic kidney disease: outcomes from a tertiary care center. J Endourol 36:600–609
pubmed: 34861766 doi: 10.1089/end.2021.0514
Izol V, Deger M, Akdogan N, Ok F, Bayazit Y, Aridogan IA (2021) The effect of percutaneous nephrolithotomy on the estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 35:583–588
pubmed: 33054416 doi: 10.1089/end.2020.0512
Zeng T, Chen D, Wu W et al (2020) Optimal perioperative antibiotic strategy for kidney stone patients treated with percutaneous nephrolithotomy. Int J Infect Dis 97:162–166
pubmed: 32502660 doi: 10.1016/j.ijid.2020.05.095
Chew BH, Miller NL, Abbott JE et al (2018) A randomized controlled trial of preoperative prophylactic antibiotics prior to percutaneous nephrolithotomy in a low infectious risk population: a report from the EDGE consortium. J Urol 200:801–808
pubmed: 29684391 doi: 10.1016/j.juro.2018.04.062
Sur RL, Krambeck AE, Large T et al (2021) A randomized controlled trial of preoperative prophylactic antibiotics for percutaneous nephrolithotomy in moderate to high infectious risk population: a report from the EDGE consortium. J Urol 205:1379–1386
pubmed: 33369488 doi: 10.1097/JU.0000000000001582
Xu P, Zhang S, Zhang Y et al (2022) Preoperative antibiotic therapy exceeding 7 days can minimize infectious complications after percutaneous nephrolithotomy in patients with positive urine culture. World J Urol 40:193–199
pubmed: 34550426 doi: 10.1007/s00345-021-03834-y
Patel N, Shi W, Liss M et al (2015) Multidrug resistant bacteriuria before percutaneous nephrolithotomy predicts for postoperative infectious complications. J Endourol 29:531–536
pubmed: 25424241 doi: 10.1089/end.2014.0776
Liu M, Chen J, Gao M et al (2021) Preoperative midstream urine cultures vs renal pelvic urine culture or stone culture in predicting systemic inflammatory response syndrome and urosepsis after percutaneous nephrolithotomy: a systematic review and meta-analysis. J Endourol 35:1467–1478
pubmed: 34128382 doi: 10.1089/end.2020.1140
Walton-Diaz A, Vinay JI, Barahona J et al (2017) Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study. Int Urol Nephrol 49:31–35
pubmed: 27848063 doi: 10.1007/s11255-016-1457-y
Ripa F, Pietropaolo A, Montanari E, Hameed BMZ, Gauhar V, Somani BK (2022) Association of kidney stones and recurrent UTIs: the chicken and egg situation. a systematic review of literature. Curr Urol Rep 23:165–174
pubmed: 35877059 pmcid: 9492590 doi: 10.1007/s11934-022-01103-y
Alsawi M, Amer T, Mariappan M, Nalagatla S, Ramsay A, Aboumarzouk O (2020) Conservative management of staghorn stones. Ann R Coll Surg Engl 102:243–247
pubmed: 31918554 pmcid: 7099166 doi: 10.1308/rcsann.2019.0176
Deutsch PG, Subramonian K (2016) Conservative management of staghorn calculi: a single-centre experience. BJU Int 118:444–450
pubmed: 26663811 doi: 10.1111/bju.13393
Meretyk S, Gofrit ON, Gafni O et al (1997) Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. J Urol 157:780–786
pubmed: 9072566 doi: 10.1016/S0022-5347(01)65039-0
Al-Kohlany KM, Shokeir AA, Mosbah A et al (2005) Treatment of complete staghorn stones: a prospective randomized comparison of open surgery versus percutaneous nephrolithotomy. J Urol 173:469–473
pubmed: 15643212 doi: 10.1097/01.ju.0000150519.49495.88
Zeng G, Cai C, Duan X et al (2021) Mini percutaneous nephrolithotomy is a noninferior modality to standard percutaneous nephrolithotomy for the management of 20–40 mm renal calculi: a multicenter randomized controlled trial. Eur Urol 79:114–121
pubmed: 32994063 doi: 10.1016/j.eururo.2020.09.026
Zhong W, Zeng G, Wu W, Chen W, Wu K (2011) Minimally invasive percutaneous nephrolithotomy with multiple mini tracts in a single session in treating staghorn calculi. Urol Res 39:117–122
pubmed: 20821200 doi: 10.1007/s00240-010-0308-z
Zhu W, Li J, Yuan J et al (2017) A prospective and randomised trial comparing fluoroscopic, total ultrasonographic, and combined guidance for renal access in mini-percutaneous nephrolithotomy. BJU Int 119:612–618
pubmed: 27862806 doi: 10.1111/bju.13703
El-Nahas AR, Elshal AM, El-Tabey NA, El-Assmy AM, Shokeir AA (2016) Percutaneous nephrolithotomy for staghorn stones: a randomised trial comparing high-power holmium laser versus ultrasonic lithotripsy. BJU Int 118:307–312
pubmed: 26779990 doi: 10.1111/bju.13418
Liu YH, Jhou HJ, Chou MH et al (2022) Endoscopic combined intrarenal surgery versus percutaneous nephrolithotomy for complex renal stones: a systematic review and meta-analysis. J Pers Med 12:532
pubmed: 35455648 pmcid: 9028407 doi: 10.3390/jpm12040532
Marguet CG, Springhart WP, Tan YH et al (2005) Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int 96:1097–1100
pubmed: 16225535 doi: 10.1111/j.1464-410X.2005.05808.x
Bryniarski P, Paradysz A, Zyczkowski M, Kupilas A, Nowakowski K, Bogacki R (2012) A randomized controlled study to analyze the safety and efficacy of percutaneous nephrolithotripsy and retrograde intrarenal surgery in the management of renal stones more than 2 cm in diameter. J Endourol 26:52–57
pubmed: 22003819 doi: 10.1089/end.2011.0235
Giusti G, Proietti S, Luciani LG et al (2014) Is retrograde intrarenal surgery for the treatment of renal stones with diameters exceeding 2 cm still a hazard? Can J Urol 21:7207–7212
pubmed: 24775573
Tracy CR, Ghareeb GM, Paul CJ et al (2018) Increasing the size of ureteral access sheath during retrograde intrarenal surgery improves surgical efficiency without increasing complications. World J Urol 36:971–978
pubmed: 29380131 doi: 10.1007/s00345-018-2204-z
Gao X, Zhang Z, Li X et al (2022) High stone-free rate immediately after suctioning flexible ureteroscopy with Intelligent pressure-control in treating upper urinary tract calculi. BMC Urol 22:180
pubmed: 36357903 pmcid: 9650831 doi: 10.1186/s12894-022-01126-0
Lai D, He Y, Li X, Chen M, Zeng X (2020) RIRS with vacuum-assisted ureteral access sheath versus MPCNL for the treatment of 2–4 cm renal stone. Biomed Res Int 2020:8052013
pubmed: 32509870 pmcid: 7245689 doi: 10.1155/2020/8052013
Ventimiglia E, Godínez AJ, Traxer O, Somani BK (2020) Cost comparison of single-use versus reusable flexible ureteroscope: a systematic review. Turk J Urol 46:S40–S45
pubmed: 32877637 pmcid: 7731961 doi: 10.5152/tud.2020.20223
Borofsky MS, Lingeman JE (2015) The role of open and laparoscopic stone surgery in the modern era of endourology. Nat Rev Urol 12:392–400
pubmed: 26077995 doi: 10.1038/nrurol.2015.141
King SA, Klaassen Z, Madi R (2014) Robot-assisted anatrophic nephrolithotomy: description of technique and early results. J Endourol 28:325–329
pubmed: 24147980 doi: 10.1089/end.2013.0597
Ilker NY, Alican Y, Simsek F, Türkeri LN, Akdas A (1993) Extracorporeal shock wave lithotripsy monotherapy of staghorn calculi with Dornier MFL 5000. J Endourol 7:281–283
pubmed: 8252018 doi: 10.1089/end.1993.7.281
Eisenberger F, Rassweiler J, Bub P et al (1987) Differentiated approach to staghorn calculi using extra-corporeal shock wave lithotripsy and percutaneous nephrolithotomy: an analysis of 151 consecutive cases. World J Urol 5:248
doi: 10.1007/BF00327229
Sharbaugh A, Morgan Nikonow T, Kunkel G, Semins MJ (2019) Contemporary best practice in the management of staghorn calculi. Ther Adv Urol 11:1756287219847099
pubmed: 35173810 pmcid: 8842174 doi: 10.1177/1756287219847099
Lottmann HB, Traxer O, Archambaud F, Mercier-Pageyral B (2001) Monotherapy extracorporeal shock wave lithotripsy for the treatment of staghorn calculi in children. J Urol 165:2324–2327
pubmed: 11371942 doi: 10.1016/S0022-5347(05)66195-2
Orsola A, Diaz I, Caffaratti J, Izquierdo F, Alberola J, Garat JM (1999) Staghorn calculi in children: treatment with monotherapy extracorporeal shock wave lithotripsy. J Urol 162:1229–1233
pubmed: 10458473 doi: 10.1016/S0022-5347(01)68142-4
Zanetti G, Paparella S, Ferruti M, Gelosa M, Abed D, Rocco F (2010) High burden stones: the role of SWL. Arch Ital Urol Androl 82:43–44
pubmed: 20593719
Shahrour K, Tomaszewski J, Ortiz T et al (2012) Predictors of immediate postoperative outcome of single-tract percutaneous nephrolithotomy. Urology 80:19–25
pubmed: 22554594 doi: 10.1016/j.urology.2011.12.065
Merhej S, Jabbour M, Samaha E et al (1998) Treatment of staghorn calculi by percutaneous nephrolithotomy and SWL: the Hotel Dieu de France experience. J Endourol 12:5–8
pubmed: 9531142 doi: 10.1089/end.1998.12.5
Bernardo NO, Smith AD (2000) Chemolysis of urinary calculi. Urol Clin North Am 27:355–365
pubmed: 10778477 doi: 10.1016/S0094-0143(05)70264-0
Kachrilas S, Papatsoris A, Bach C et al (2013) The current role of percutaneous chemolysis in the management of urolithiasis: review and results. Urolithiasis 41:323–326
pubmed: 23743991 doi: 10.1007/s00240-013-0575-6
Gonzalez RD, Whiting BM, Canales BK (2012) The history of kidney stone dissolution therapy: 50 years of optimism and frustration with renacidin. J Endourol 26:110–118
pubmed: 21999455 pmcid: 3311908 doi: 10.1089/end.2011.0380
Øbro LF, Sloth Osther S, Osther PJS, Jung H (2022) Case of the month from Lillebaelt hospital, University Hospital of South Denmark, Denmark: Renacidin® - still a useful adjunct to endoscopic surgery for complex renal struvite stone disease. BJU Int 130:437–440
pubmed: 36102583 pmcid: 9543700 doi: 10.1111/bju.15822
Rodman JS, Williams JJ, Peterson CM (1984) Dissolution of uric acid calculi. J Urol 131:1039–1044
pubmed: 6726897 doi: 10.1016/S0022-5347(17)50798-3
Gokce MI, Ozden E, Suer E, Gulpinar B, Gulpınar O, Tangal S (2015) Comparison of imaging modalities for detection of residual fragments and prediction of stone related events following percutaneous nephrolitotomy. Int Braz J Urol 41:86–90
pubmed: 25928513 pmcid: 4752060 doi: 10.1590/S1677-5538.IBJU.2015.01.12
Olvera-Posada D, Ali SN, Dion M, Alenezi H, Denstedt JD, Razvi H (2016) Natural history of residual fragments after percutaneous nephrolithotomy: evaluation of factors related to clinical events and intervention. Urology 97:46–50
pubmed: 27421779 doi: 10.1016/j.urology.2016.06.049
Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324
pubmed: 24857648 doi: 10.1016/j.juro.2014.05.006
Prezioso D, Barone B, Di Domenico D, Vitale R (2019) Stone residual fragments: a thorny problem. Urologia 86:169–176
pubmed: 31304880 doi: 10.1177/0391560319860654
Suarez-Ibarrola R, Hein S, Miernik A (2019) Residual stone fragments: clinical implications and technological innovations. Curr Opin Urol 29:129–134
pubmed: 30407220 doi: 10.1097/MOU.0000000000000571
Long Q, Zhang J, Xu Z et al (2016) A prospective randomized controlled trial of the efficacy of external physical vibration lithecbole after extracorporeal shock wave lithotripsy for a lower pole renal stone less than 2 cm. J Urol 195:965–970
pubmed: 26555953 doi: 10.1016/j.juro.2015.10.174
Wu W, Yang Z, Xu C et al (2017) External physical vibration lithecbole promotes the clearance of upper urinary stones after retrograde intrarenal surgery: a prospective, multicenter, randomized controlled trial. J Urol 197:1289–1295
pubmed: 28063841 doi: 10.1016/j.juro.2017.01.001
Zeng T, Tiselius HG, Huang J, Deng T, Zeng G, Wu W (2020) Effect of mechanical percussion combined with patient position change on the elimination of upper urinary stones/fragments: a systematic review and meta-analysis. Urolithiasis 48:95–102
pubmed: 31062070 doi: 10.1007/s00240-019-01140-2
Wu W, Yang D, Tiselius HG et al (2014) The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results. Urology 83:732–737
pubmed: 24485999 doi: 10.1016/j.urology.2013.11.012
Li S, Iremashvili V, Vernez SL et al (2021) Effect of stone composition on surgical stone recurrence: single center longitudinal analysis. Can J Urol 28:10744–10749
pubmed: 34378509
Pietrow PK, Karellas ME (2006) Medical management of common urinary calculi. Am Fam Physician 74:86–94
pubmed: 16848382
Wang LP, Wong HY, Griffith DP (1997) Treatment options in struvite stones. Urol Clin North Am 24:149–162
pubmed: 9048858 doi: 10.1016/S0094-0143(05)70360-8
Jarrar K, Boedeker RH, Weidner W (1996) Struvite stones: long term follow up under metaphylaxis. Ann Urol (Paris) 30:112–117
pubmed: 8766146
Wall I, Tiselius HG (1990) Long-term acidification of urine in patients treated for infected renal stones. Urol Int 45:336–341
pubmed: 2288050 doi: 10.1159/000281732
Griffith DP, Gleeson MJ, Lee H et al (1991) Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 20:243–247
pubmed: 1726639 doi: 10.1159/000471707

Auteurs

Wen Zhong (W)

Department of Urology and Key Laboratory of Guangdong, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID: 0000-0003-0540-7195

Palle Osther (P)

Department of Urology, Lillebaelt Hospital, University of Southern Denmark, Vejle, Denmark.

Margaret Pearle (M)

Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA.

Simon Choong (S)

Department of Urology, Westmoreland Street Hospital, University College Hospital London, London, UK.

Giorgio Mazzon (G)

Department of Urology, San Bassiano Hospital, Vicenza, Italy.

Wei Zhu (W)

Department of Urology and Key Laboratory of Guangdong, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Zhijian Zhao (Z)

Department of Urology and Key Laboratory of Guangdong, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Jorge Gutierrez (J)

Department of Urology, Wake Forest Baptist Health, Winston-Salem, NC, USA.

Daron Smith (D)

Department of Urology, Westmoreland Street Hospital, University College Hospital London, London, UK.

Mohamad Moussa (M)

Department of Urology, Al Zahraa Hospital University Medical Center and Lebanese University, Beirut, Lebanon.

Shashi Kiran Pal (SK)

Department of Urology, Holy Family Hospital, New Delhi, India.

Iliya Saltirov (I)

Department of Urology and Nephrology, Military Medical Academy, Sofia, Bulgaria.

Mumtaz Ahmad (M)

Department of Urology, Ganga Ram Hospital, Ganga Ram Hospital and Fatima Jinnah Medical University, Lahore, Punjab, Pakistan.

Saeed Bin Hamri (SB)

Division of Urology, Department of Surgery, Ministry of the National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Ben Chew (B)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Albert Aquino (A)

Department of Urology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.

Amy Krambeck (A)

Department of Urology, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Sanjay Khadgi (S)

Department of Urology, Vayodha Hospital, Kathmandu, Nepal.

Roger L Sur (RL)

Department of Urology, University of California San Diego Comprehensive Kidney Stone Center, San Diego, CA, USA.

Selcuk Güven (S)

Department of Urology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

Wael Gamal (W)

Department of Urology, Sohag University Hospital, Sohâg, Egypt.

Jianxing Li (J)

Department of Urology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Yongda Liu (Y)

Department of Urology and Key Laboratory of Guangdong, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Stefania Ferretti (S)

Department of Urology, Hospital, University of Parma, Parma, Italy.

Wissam Kamal (W)

Department of Urology, King Fahad Hospital, Jeddah, Saudi Arabia.

Liefu Ye (L)

Urology Department, Fujian Provincial Hospital, Fujian, China.

Norberto Bernardo (N)

Department of Urology, Hospital de Clinicas Jose de San Martin, Buenos Aires, Argentina.

Shabir Almousawi (S)

Department of Urology, Sabah Al-Ahmad Urology Centre, Kuwait City, Kuwait.

Mohamed Abdelkareem (M)

Department of Urology, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar.

Otas Durutovic (O)

Department of Urology, Clinic of Urology, University of Belgrade, Belgrade, Serbia.

Guido Kamphuis (G)

Department of Urology, Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands.

Marcus Maroccolo (M)

Department of Urology, Hospital de Base of the Federal District, Brasília, Brazil.

Zhangqun Ye (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Peter Alken (P)

Department of Urology, University Clinic Mannheim, Mannheim, Germany. Peter.Alken@medma.uni-heidelberg.de.

Kermal Sarica (K)

Department of Urology, Medical School, Biruni University, Istanbul, Turkey. saricakemal@gmail.com.

Guohua Zeng (G)

Department of Urology and Key Laboratory of Guangdong, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. gzgyzgh@vip.sina.com.

Classifications MeSH